Long term effects of fusidic acid on bacterial protein synthesis in vivo.
D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D001410:Bacillus megaterium / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D001426:Bacterial Proteins / Q000096:biosynthesis*; D001665:Binding Sites; D002499:Centrifugation, Density Gradient; D002701:Chloramphenicol / Q000494:pharmacology; D002751:Chlortetracycline / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005672:Fusidic Acid / Q000494:pharmacology*; D007553:Isotope Labeling; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D010759:Phosphorus Isotopes; D011523:Protoplasts / Q000187:drug effects / Q000378:metabolism; D011691:Puromycin / Q000494:pharmacology; D012270:Ribosomes / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D000903:Antibiotics, Antineoplastic; D001426:Bacterial Proteins; D010759:Phosphorus Isotopes; D014316:Tritium; D011691:Puromycin; D005672:Fusidic Acid; D004917:Erythromycin; D002701:Chloramphenicol; D007930:Leucine; D002751:Chlortetracycline